Financial reports
ARS
2023 FY
Annual report to shareholders
15 Mar 24
10-K
2023 FY
Annual report
20 Feb 24
10-Q
2023 Q3
Quarterly report
6 Nov 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
10-Q
2023 Q1
Quarterly report
9 May 23
ARS
2022 FY
Annual report to shareholders
24 Mar 23
10-K
2022 FY
Annual report
21 Feb 23
10-Q
2022 Q3
Quarterly report
8 Nov 22
10-Q
2022 Q2
Quarterly report
9 Aug 22
10-Q
2022 Q1
Quarterly report
10 May 22
Current reports
8-K
Submission of Matters to a Vote of Security Holders
26 Apr 24
8-K
Halozyme Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
20 Feb 24
8-K
Results of Operations and Financial Condition
17 Jan 24
8-K
Halozyme Reports Third Quarter 2023 Financial and Operating Results
6 Nov 23
8-K
Other Events
7 Sep 23
8-K
Halozyme Reports Second Quarter 2023 Financial and Operating Results
8 Aug 23
8-K
Halozyme Reports First Quarter 2023 Financial and Operating Results
9 May 23
8-K
Submission of Matters to a Vote of Security Holders
8 May 23
8-K
Halozyme Provides Update on Licensee Co-formulation Patent Hearing In Europe
15 Mar 23
8-K
Other Events
13 Mar 23
Registration and prospectus
SC TO-T/A
Third party tender offer statement (amended)
24 May 22
SC TO-T/A
Third party tender offer statement (amended)
12 May 22
SC TO-T/A
Third party tender offer statement (amended)
2 May 22
SC TO-T
Third party tender offer statement
26 Apr 22
SC TO-C
Information about tender offer
13 Apr 22
SC TO-C
Information about tender offer
13 Apr 22
SC TO-C
Information about tender offer
13 Apr 22
S-8
Registration of securities for employees
5 May 21
S-8
Registration of securities for employees
5 May 21
S-8 POS
Registration of securities for employees (post-effective amendment)
14 May 19
Proxies
DEFA14A
Additional proxy soliciting materials
15 Mar 24
DEF 14A
Definitive proxy
15 Mar 24
PRE 14A
Preliminary proxy
4 Mar 24
DEFA14A
Additional proxy soliciting materials
24 Mar 23
DEF 14A
Definitive proxy
24 Mar 23
DEFA14A
Additional proxy soliciting materials
18 Apr 22
DEFA14A
Additional proxy soliciting materials
25 Mar 22
DEF 14A
Definitive proxy
25 Mar 22
DEFA14A
Additional proxy soliciting materials
26 Mar 21
DEF 14A
Definitive proxy
26 Mar 21
Other
UPLOAD
Letter from SEC
21 Jul 23
CORRESP
Correspondence with SEC
28 Jun 23
UPLOAD
Letter from SEC
14 Jun 23
CT ORDER
Confidential treatment order
20 Dec 18
CT ORDER
Confidential treatment order
14 Jun 16
UPLOAD
Letter from SEC
29 Jan 16
CORRESP
Correspondence with SEC
4 Jan 16
UPLOAD
Letter from SEC
17 Dec 15
CORRESP
Correspondence with SEC
20 Nov 15
CORRESP
Correspondence with SEC
28 Oct 15
Ownership
3
Mahesh Krishnan
25 Apr 24
4
Michael J. LaBarre
17 Apr 24
144
Notice of proposed sale of securities
17 Apr 24
144
Notice of proposed sale of securities
16 Apr 24
4
Michael J. LaBarre
26 Mar 24
4
Michael J. LaBarre
13 Mar 24
144
Notice of proposed sale of securities
13 Mar 24
144
Notice of proposed sale of securities
12 Mar 24
4
Michael J. LaBarre
28 Feb 24
144
Notice of proposed sale of securities
28 Feb 24